AlgoBio’s core product is a platform technology that functions as a molecular-testing equivalent of a compression algorithm, using AI and sophisticated algorithms to boost throughput and efficiency. The company has applied its platform across healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research. AlgoBio launched a fast Covid testing solution that is patented and is expanding its offering to include additional diagnostic tests. Its product Tapestry enables affordable campus-wide Covid-19 screening. The company recently partnered with Dhiti Omics Technologies, an Indian molecular diagnostic services provider. AlgoBio plans to use new funding to develop its sales force, support its product pipeline, and broaden its geographic reach.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2024